title: HPV as a model for the development of prophylactic and therapeutic cancer vaccines.
abstract: HPV has been linked to many human malignancies and, as such, represents a major public health crisis. The understanding of HPV biology, however, has helped tremendously in developing prophylactic vaccines, which should help in decreasing mortality due to HPV infections. Understanding HPV biology has allowed researchers to use the virus as a model for the development of not only prophylactic vaccines, but also therapeutic ones. The advantages of HPV as a model stem from the limited number of proteins encoded by the HPV genome that can be targeted by vaccines, and also from the restricted expression of certain viral proteins during different stages of infection. In this review, we discuss how HPV can be used as a model for the development of both prophylactic and therapeutic vaccines.
authors.affiliation: Cancer Vaccine Section, National Cancer Institute, NCI-NNMC, Bldg 10, Rm. 5101, Bethesda, MD 20889, USA.
authors.forename: Raed N
authors.initials: RN
authors.lastname: Samara
authors.forename: Samir N
authors.initials: SN
authors.lastname: Khleif
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use*; D006801:Humans; D018448:Models, Immunological; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use; D014764:Viral Proteins / Q000276:immunology
chemical_list: D019496:Cancer Vaccines; D053918:Papillomavirus Vaccines; D014764:Viral Proteins
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references.pmid: 15734974
references.citation: Cancer J Sci Am. 1996 Mar-Apr;2(2):91-8
references.pmid: 9166506
references.citation: J Immunother. 2000 Mar-Apr;23(2):255-66
references.pmid: 10746552
references.citation: J Gen Virol. 2000 Jul;81(Pt 7):1825-32
references.pmid: 10859389
references.citation: Vaccine. 2004 Jan 26;22(5-6):670-80
references.pmid: 14741159
references.citation: Clin Cancer Res. 1998 Sep;4(9):2103-9
references.pmid: 9748126
references.citation: J Gen Virol. 2007 Mar;88(Pt 3):803-813
references.pmid: 17325352
references.citation: Gynecol Oncol. 2008 May;109(2 Suppl):S15-21
references.pmid: 18474288
references.citation: Virology. 2000 May 10;270(2):254-7
references.pmid: 10792983
references.citation: J Natl Cancer Inst Monogr. 2003;(31):111-6
references.pmid: 12807954
references.citation: Annu Rev Biophys Biomol Struct. 2002;31:343-60
references.pmid: 11988474
references.citation: Science. 1990 Apr 6;248(4951):76-9
references.pmid: 2157286
references.citation: N Engl J Med. 2007 May 10;356(19):1915-27
references.pmid: 17494925
references.citation: Gynecol Oncol. 2007 Sep;106(3):558-66
references.pmid: 17631950
references.citation: Int J Gynecol Pathol. 1993 Apr;12(2):186-92
references.pmid: 8463044
references.citation: Liver Transpl. 2000 May;6(3):253-62
references.pmid: 10827224
references.citation: J Occup Environ Med. 2003 Jan;45(1):5-14
references.pmid: 12553174
references.citation: Virology. 1991 Nov;185(1):251-7
references.pmid: 1656586
references.citation: N Engl J Med. 2007 May 10;356(19):1928-43
references.pmid: 17494926
references.citation: Int J Cancer. 1974 May 15;13(5):650-6
references.pmid: 4367340
references.citation: Virology. 2003 Sep 30;314(2):630-5
references.pmid: 14554090
references.citation: BMJ. 1995 Nov 18;311(7016):1346
references.pmid: 7496288
references.citation: Surg Today. 2000;30(1):82-5
references.pmid: 10648091
references.citation: Annu Rev Microbiol. 1994;48:427-47
references.pmid: 7826013
references.citation: Cancer Gene Ther. 2006 Jun;13(6):592-7
references.pmid: 16456551
references.citation: J Virol. 1993 Jan;67(1):315-22
references.pmid: 8380079
references.citation: EMBO J. 1989 Dec 20;8(13):4099-105
references.pmid: 2556261
references.citation: N Engl J Med. 1997 Nov 6;337(19):1350-8
references.pmid: 9358129
references.citation: Eur J Gynaecol Oncol. 2004;25(2):151-6
references.pmid: 15032271
references.citation: Clin Cancer Res. 2000 Sep;6(9):3406-16
references.pmid: 10999722
references.citation: Virology. 2004 Jun 20;324(1):17-27
references.pmid: 15183049
references.citation: Vaccine. 2000 Jul 1;18(26):2937-44
references.pmid: 10825594
references.citation: Ann Transplant. 1997;2(4):5-6
references.pmid: 9869871
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
references.pmid: 16949997
references.citation: Cancer Immunol Immunother. 2004 Jul;53(7):642-50
references.pmid: 14985860
references.citation: Expert Opin Biol Ther. 2001 Jul;1(4):571-81
references.pmid: 11727495
references.citation: Lancet. 2007 Jun 30;369(9580):2161-2170
references.pmid: 17602732
references.citation: Vaccine. 2001 Jan 8;19(11-12):1496-502
references.pmid: 11163673
references.citation: Oncology (Williston Park). 1994 Aug;8(8):83-9; discussion 89, 93-4
references.pmid: 7947005
references.citation: J Natl Cancer Inst. 1997 Sep 3;89(17):1285-93
references.pmid: 9293919
references.citation: Obstet Gynecol. 2004 Feb;103(2):317-26
references.pmid: 14754702
references.citation: Cell. 1990 Dec 21;63(6):1129-36
references.pmid: 2175676
references.citation: Expert Rev Vaccines. 2003 Jun;2(3):381-9
references.pmid: 12903803
references.citation: Lancet. 2006 Apr 15;367(9518):1247-55
references.pmid: 16631880
references.citation: Semin Oncol. 1995 Feb;22(1):61-6
references.pmid: 7855620
references.citation: Am J Obstet Gynecol. 2004 Jul;191(1):114-20
references.pmid: 15295351
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/122-31
references.pmid: 16949999
references.citation: Eur J Cancer. 1999 Jun;35(6):946-52
references.pmid: 10533477
references.citation: Bull Pan Am Health Organ. 1996 Dec;30(4):362-77
references.pmid: 9041748
references.citation: Int J Cancer. 2006 Jun 15;118(12):3022-9
references.pmid: 16425257
references.citation: Hum Gene Ther. 2004 May;15(5):421-31
references.pmid: 15144573
references.citation: Hum Vaccin. 2007 Jul-Aug;3(4):109-15
references.pmid: 17611417
references.citation: Cancer Res. 2002 Jan 15;62(2):472-9
references.pmid: 11809698
references.citation: J Virol. 1999 Jul;73(7):6188-90
references.pmid: 10364381
references.citation: Proc Soc Exp Biol Med. 1949 Oct;72(1):46-50
references.pmid: 15403582
references.citation: Eur J Gynaecol Oncol. 1992;13(1):45-52
references.pmid: 1532145
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51
references.pmid: 16950017
references.citation: J Biol Chem. 2005 Oct 28;280(43):36088-98
references.pmid: 16135518
references.citation: J Infect Dis. 2000 Jun;181(6):1911-9
references.pmid: 10837170
references.citation: Virology. 2005 Jul 5;337(2):365-72
references.pmid: 15885736
references.citation: Cancer Sci. 2007 Oct;98(10):1505-11
references.pmid: 17645777
references.citation: Lancet Oncol. 2005 May;6(5):271-8
references.pmid: 15863374
references.citation: J Natl Cancer Inst. 1993 Jun 16;85(12):958-64
references.pmid: 8388478
references.citation: J Virol. 2000 Oct;74(20):9712-6
references.pmid: 11000243
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: Viral Immunol. 2008 Jun;21(2):225-33
references.pmid: 18476769
references.citation: J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
references.pmid: 7791229